Skip to main content
SpringerLink
Log in

Men’s Health

Summary and Table

  • Section 2: Men’s Health
  • Adis Profile Summary
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Martin CW. Cross cultural acceptability of hormonal male contraception [abstract]. Acta Obstet Gynaecol Scand 1997; 167 Suppl. 76: P72.62

    Google Scholar 

  2. Guay AT. Treatment of erectile dysfunction in men with diabetes. Diabetes Spectrum 1998; 11 (2): 101–11

    Google Scholar 

  3. Olsen EA. Androgenic alopecia. In: Disorders of hair growth: diagnosis and treatment. New York: McGraw-Hill Inc., 1993: 257–83

    Google Scholar 

  4. Norwood O’TT. Male pattern baldness: classification and incidence. South Med J 1975; 68 (11): 1359–65

    Article  PubMed  CAS  Google Scholar 

  5. Ebeling PR. Osteoporosis in men: new insights into aetiology, pathogenesis, prevention and management. Drugs Aging 1998; 13 (6): 421–34

    Article  PubMed  CAS  Google Scholar 

  6. Jack D. Hard data on stronger bones. Inpharma 1999 Jul 17; 1196: 13–4

    Article  Google Scholar 

  7. Maas D, Jochen A, Lalande B. Age-related changes in male gonadal function: implications for therapy. Drugs Aging 1997; 11 (1): 45–60

    Article  PubMed  CAS  Google Scholar 

  8. Jones GW. Prostate cancer. Magnitude of the problem. American College of Surgeons database and epidemiologic study. Cancer 1993; 71 (3 Suppl.): 887–90

    Article  PubMed  CAS  Google Scholar 

  9. Schröder FH, Boyle P. Screening for prostate cancer - necessity or nonsense? Eur J Cancer 1993; 29A: 656–61

    Article  PubMed  Google Scholar 

  10. Schröder FH. Prostate cancer: to screen or not to screen? Br Med J 1993; 306: 407–8

    Article  Google Scholar 

  11. Walsh PC. Human benign prostatic hyperplasia: etiological considerations. Prog Clin Biol Res 1984; 145; 1–25

    PubMed  CAS  Google Scholar 

  12. Oesterling JE. Benign prostatic hyperplasia: its natural history, epidemiological characteristics and surgical treatment. Arch Fam Med 1992; 1: 257–66

    Article  PubMed  CAS  Google Scholar 

  13. Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 1990; 17: 495–507

    PubMed  CAS  Google Scholar 

  14. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: 469–71

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Adis International Ltd, Auckland, New Zealand

    Katharine J. Palmer, Lynda Wiseman & Raewyn Poole

Authors
  1. Katharine J. Palmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lynda Wiseman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raewyn Poole
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palmer, K.J., Wiseman, L. & Poole, R. Men’s Health. Drugs R&D 2, 401–411 (1999). https://doi.org/10.2165/00126839-199902060-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902060-00010

Keywords

Search

Navigation